case_images: PMC11362812_01
case_images: Clinical course of therapy and treatment lengths for Case 1 (A), Case 2 (B), and Case 3 (C).
case_images: fonc-14-1419246-g001.jpg
case_images: PMC11362812_03_fonc-14-1419246-g001.jpg
case_images: f1
case_images: A 54-year-old woman with no significant family or social history potentially related to BC was initially diagnosed with clinical stage IV (cT2cN1(f)M1) IDC of the right breast that was ER+/PR+ (90%/75%) and HER2+ (>30%) as well as high-grade ductal carcinoma in situ of the right breast (Figure 1).
case_images: PMC11362812_02
case_images: Clinical course of therapy and treatment lengths for Case 1 (A), Case 2 (B), and Case 3 (C).
case_images: fonc-14-1419246-g001.jpg
case_images: PMC11362812_03_fonc-14-1419246-g001.jpg
case_images: f1
case_images: A 54-year-old woman with no significant family or social history potentially related to BC was initially diagnosed with clinical stage IV (cT2cN1(f)M1) IDC of the right breast that was ER+/PR+ (90%/75%) and HER2+ (>30%) as well as high-grade ductal carcinoma in situ of the right breast (Figure 1).
case_images: PMC11362812_03
case_images: Clinical course of therapy and treatment lengths for Case 1 (A), Case 2 (B), and Case 3 (C).
case_images: fonc-14-1419246-g001.jpg
case_images: PMC11362812_03_fonc-14-1419246-g001.jpg
case_images: f1
case_images: A 54-year-old woman with no significant family or social history potentially related to BC was initially diagnosed with clinical stage IV (cT2cN1(f)M1) IDC of the right breast that was ER+/PR+ (90%/75%) and HER2+ (>30%) as well as high-grade ductal carcinoma in situ of the right breast (Figure 1).